EUVIMEDEUVIMED entdecken
Leserbrief

The role of baseline hepatic function in interpreting adverse events among patients with hepatocellular carcinoma

Duygu Ercan Uzundal iD

Journal of Oncology Pharmacy Practice · 14.11.2026

DOI: 10.1177/10781552261506798 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Oncology Pharmacy Practice, online erschienen am 14.11.2026. Verfasst von Duygu Ercan Uzundal. Beteiligte Einrichtung: Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara, Türkiye. Die Arbeit nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara, Türkiye.

ORCID-Profile: Duygu Ercan Uzundal

Zitieren

APA

Ercan Uzundal, D. (2026). The role of baseline hepatic function in interpreting adverse events among patients with hepatocellular carcinoma. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552261506798

Vancouver

Ercan Uzundal D. The role of baseline hepatic function in interpreting adverse events among patients with hepatocellular carcinoma. Journal of Oncology Pharmacy Practice. 2026. doi:10.1177/10781552261506798

BibTeX
@article{ErcanUzundal2026,
  author = {Ercan Uzundal, Duygu},
  title = {The role of baseline hepatic function in interpreting adverse events among patients with hepatocellular carcinoma},
  journal = {Journal of Oncology Pharmacy Practice},
  year = {2026},
  doi = {10.1177/10781552261506798}
}
Kostenlos starten →